Literature DB >> 35760899

CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9.

Yuwei Zhang1, Fengping Liu2, Yangkun Feng3, Xinyu Xu1, Yang Wang1, Sha Zhu4, Jian Dong1, Shanchao Zhao5,6, Bin Xu7, Ninghan Feng8,9.   

Abstract

Circular RNAs (circRNAs) have been demonstrated to play vital roles in cancer development and progression. However, studies on the association between circRNAs and prostate cancer (PCa) are still lacking. CircRNA sequencing of two pairs of PCa tissues and adjacent normal tissues was conducted in the present study, and qRT-PCR was performed to verify the results. Functional experiments were performed to investigate cellular functions after specific changes. Mass spectrometry analysis after RNA pull-down experiments and Co-IP assays were further conducted. Downstream target proteins were predicted via online databases and detected in vitro by Western blot analysis and in vivo by immunohistochemistry. Hsa_circ_0006156 (subsequently named circ_0006156) expresses at low levels in both PCa tissues and cells, and it significantly inhibits the migration and invasion of PCa cells. Circ_0006156 binds to and blocks the ubiquitination of S100A9. Moreover, functional assays revealed that circ_0006156 represses the malignant progression of PCa by binding to S100A9. Finally, in vivo experiments showed that circ_0006156 suppresses PCa migration and invasion by increasing S100A9, revealing circ_0006156 as a potential novel effective target for PCa treatment.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35760899     DOI: 10.1038/s41417-022-00492-z

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  41 in total

Review 1.  The biogenesis, biology and characterization of circular RNAs.

Authors:  Lasse S Kristensen; Maria S Andersen; Lotte V W Stagsted; Karoline K Ebbesen; Thomas B Hansen; Jørgen Kjems
Journal:  Nat Rev Genet       Date:  2019-08-08       Impact factor: 53.242

Review 2.  Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion.

Authors:  Katherine S Virgo; Ethan Basch; D Andrew Loblaw; Thomas K Oliver; R Bryan Rumble; Michael A Carducci; Luke Nordquist; Mary-Ellen Taplin; Eric Winquist; Eric A Singer
Journal:  J Clin Oncol       Date:  2017-04-25       Impact factor: 44.544

Review 3.  Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.

Authors:  Julia Beermann; Maria-Teresa Piccoli; Janika Viereck; Thomas Thum
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 4.  Androgen deprivation therapy for prostate cancer.

Authors:  Nima Sharifi; James L Gulley; William L Dahut
Journal:  JAMA       Date:  2005-07-13       Impact factor: 56.272

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 6.  Landscape of Noncoding RNA in Prostate Cancer.

Authors:  Junjie T Hua; Sujun Chen; Housheng H He
Journal:  Trends Genet       Date:  2019-10-14       Impact factor: 11.639

Review 7.  Prostate cancer.

Authors:  Richard J Rebello; Christoph Oing; Karen E Knudsen; Stacy Loeb; David C Johnson; Robert E Reiter; Silke Gillessen; Theodorus Van der Kwast; Robert G Bristow
Journal:  Nat Rev Dis Primers       Date:  2021-02-04       Impact factor: 52.329

Review 8.  Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies.

Authors:  Sumeng Wang; Ke Zhang; Shanyue Tan; Junyi Xin; Qianyu Yuan; Huanhuan Xu; Xian Xu; Qi Liang; David C Christiani; Meilin Wang; Lingxiang Liu; Mulong Du
Journal:  Mol Cancer       Date:  2021-01-11       Impact factor: 27.401

Review 9.  Circular RNA: metabolism, functions and interactions with proteins.

Authors:  Wei-Yi Zhou; Ze-Rong Cai; Jia Liu; De-Shen Wang; Huai-Qiang Ju; Rui-Hua Xu
Journal:  Mol Cancer       Date:  2020-12-14       Impact factor: 27.401

10.  Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.

Authors:  Xiaohong Hong; Na Liu; Yelin Liang; Qingmei He; Xiaojing Yang; Yuan Lei; Panpan Zhang; Yin Zhao; Shiwei He; Yaqin Wang; Junyan Li; Qian Li; Jun Ma; Yingqin Li
Journal:  Mol Cancer       Date:  2020-02-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.